Compare LGND & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGND | MEOH |
|---|---|---|
| Founded | 1987 | 1968 |
| Country | United States | Canada |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | N/A | 1995 |
| Metric | LGND | MEOH |
|---|---|---|
| Price | $226.65 | $63.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $249.71 | $58.33 |
| AVG Volume (30 Days) | 179.8K | ★ 1.6M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.25 | $25.43 |
| Revenue Next Year | $19.41 | N/A |
| P/E Ratio | $76.27 | ★ $16.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $98.90 | $31.57 |
| 52 Week High | $247.38 | $66.75 |
| Indicator | LGND | MEOH |
|---|---|---|
| Relative Strength Index (RSI) | 54.80 | 60.55 |
| Support Level | $180.85 | $46.36 |
| Resistance Level | $227.92 | $66.75 |
| Average True Range (ATR) | 10.28 | 2.06 |
| MACD | 0.49 | 0.17 |
| Stochastic Oscillator | 54.83 | 94.47 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.